GS1, received on 17 December, 2013 accreditation by the U.S. Food and Drug Administration (FDA) as issuing agency for unique device identifiers (UDIs). In this interview, Ulrike Kreysa Vice President of Healthcare for GS1 global office, speaks to Andrea Charles from Pharma IQ about the importance of aligning master data, how the FDA final rule for UDIs is impacting the landscape and what's next for European regulation.
Pharma IQ: The FDA final rule for UDIs came out last year. How...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More